Oral Proteins & Peptides Market - Global Forecast 2026-2032

The oral proteins and peptides market is entering a pivotal phase, driven by scientific advancements, evolving regulatory frameworks, and innovative commercialization models. Senior decision-makers evaluating future investments will benefit from a clear understanding of the forces transforming this dynamic segment.

Market Snapshot: Oral Proteins and Peptides Market Size and Growth

The oral proteins and peptides market is projected to expand from USD 2.73 billion in 2025 to USD 2.86 billion in 2026, reaching USD 3.99 billion by 2032 with a compound annual growth rate of 5.57%. This anticipated growth reflects increased global demand for more convenient, patient-friendly alternatives to traditional injectables, supported by the adoption of novel delivery technologies. Biopharmaceutical innovators are adapting to this market shift by targeting therapies that prioritize patient adherence and ease of administration, which are highly valued in current healthcare ecosystems.

Scope & Segmentation

Product Types: Includes a wide array of insulin-based oral proteins such as combination insulin, long-acting and rapid-acting analogues, and recombinant human insulin. Also covers key peptide therapeutics, notably those based on calcitonin, GLP-1 receptor agonists, and vasopressin analogues.
Formulation Types: Consists of capsules, tablets, liquid, and powder forms, supporting varied stability requirements, patient preferences, and optimized manufacturing scalability.
Development Stages: Ranges from preclinical research through clinical trial phases I–III, extending into post-market real-world safety monitoring.
Applications: Targets therapeutics for diabetes, metabolic and hormonal disorders, some cancers, cardiovascular conditions, and other chronic diseases.
End-User Settings: Addresses home care, hospital and clinic use, specialty care centers, and research or academic environments, each with distinct delivery and compliance needs.
Geographic Regions: Focuses on America, EMEA, and Asia-Pacific, each characterized by unique regulatory expectations and commercial practices.
Supporting Technologies: Encompasses absorption enhancers, enteric coating solutions, device-assisted delivery, and streamlined fill-finish manufacturing processes that enable both product stability and large-scale production efficiency.

Key Takeaways

Advancements in drug formulation have unlocked new potential for the oral delivery of biologic medicines, addressing technical challenges that historically constrained this route to market.
Regulatory authorities are adapting pathways and standards to accommodate the stability and bioavailability needs of oral proteins and peptides, supporting a broader therapeutic development pipeline.
Payer strategies are evolving toward solutions that improve patient compliance, emphasizing resource optimization and differentiating products during contract negotiations with managed care organizations.
Localized production and expanded supplier networks have become central to mitigating operational risks, particularly as global economic and trade policies shift.
Segment-specific approaches are emerging, such as the prioritization of long-acting oral insulins for at-home management and fast-acting peptides for acute in-hospital interventions, influencing research focus and commercial planning.

Tariff Impact: Navigating Trade Policy and Localization

Recent tariffs in the United States have reshaped supply chain management within the oral proteins and peptides sector. Companies are mitigating increased import costs and market volatility by diversifying suppliers, and accelerating the shift to nearshoring and regional manufacturing models. This localized approach not only reduces exposure to unpredictable trade environments but also supports faster product launches and improved market access. As supply chain strategies evolve, broad networks and domestic production options serve as critical components of risk management in an increasingly cost-conscious payer and provider landscape.

Methodology & Data Sources

This comprehensive assessment is based on a mixed-methods approach combining structured expert interviews, analysis of technical literature, regulatory and clinical data, and patent documents. This triangulation validates findings and supports senior-level decision-making while accounting for the rapidly changing clinical and regulatory environment.

Why This Report Matters

Enables executive teams to pinpoint high-value assets, maximize R&D investment, and identify region-specific opportunities within the oral proteins and peptides market.
Equips organizations with insights into regulatory navigation, modern manufacturing strategies, and responses to trade-related disruptions.
Supports effective engagement with payers and supply chain partners by clarifying essential value levers and emerging market requirements.

Conclusion

As the oral proteins and peptides segment advances, operational intricacies and strategic options multiply. Organizations that leverage timely, accurate insights are best positioned to adapt and secure sustainable growth in a complex biopharmaceutical environment.

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates.
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025

8. Oral Proteins & Peptides Market, by Product Type

8.1. Insulin-Based Proteins
8.1.1. Combination Insulin Products
8.1.2. Long-Acting Insulin Analogues
8.1.3. Rapid-Acting Insulin Analogues
8.1.4. Recombinant Human Insulin
8.2. Peptide Therapeutics
8.2.1. Calcitonin-Based Therapies
8.2.2. Glucagon-Like Peptide-1 Receptor Agonists
8.2.3. Vasopressin Analogs

9. Oral Proteins & Peptides Market, by Formulation

9.1. Capsule Formulations
9.2. Liquid Formulations
9.3. Powder Formulations
9.4. Tablet Formulations

10. Oral Proteins & Peptides Market, by Development Stage

10.1. Phase I & II Clinical Trials
10.2. Phase III Clinical Trials
10.3. Post-Market Surveillance
10.4. Preclinical Studies

11. Oral Proteins & Peptides Market, by Application

11.1. Cancer Treatment
11.2. Cardiovascular Diseases
11.3. Diabetes Management
11.4. Hormonal Disorders

12. Oral Proteins & Peptides Market, by End-User

12.1. Home Care Settings
12.2. Hospitals & Clinics
12.3. Research Laboratories
12.4. Specialty Clinics

13. Oral Proteins & Peptides Market, by Region

13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific

14. Oral Proteins & Peptides Market, by Group

14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO

15. Oral Proteins & Peptides Market, by Country

15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea

16. United States Oral Proteins & Peptides Market
17. China Oral Proteins & Peptides Market

18. Competitive Landscape

18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. AbbVie Inc.
18.6. Amgen Inc.
18.7. Amryt Pharma plc
18.8. Astellas Pharma Inc.
18.9. AstraZeneca PLC
18.10. Biocon Limited
18.11. Boehringer Ingelheim International GmbH
18.12. Catalent, Inc.
18.13. Entera Bio Ltd. by DNA Biomedical Solutions
18.14. F. Hoffmann-La Roche AG
18.15. Hunan Huateng Pharmaceutical Co., Ltd. by Tasly Capital
18.16. Johnson & Johnson Services, Inc.
18.17. Merck KGaA
18.18. Novartis AG
18.19. Novo Nordisk A/S
18.20. Oramed Pharmaceuticals Inc.
18.21. PeptiDream Inc.
18.22. Pfizer, Inc.
18.23. Protagonist Therapeutics, Inc.
18.24. Proxima Concepts Limited
18.25. Rani Therapeutics, LLC
18.26. Sanofi S.A.
18.27. Tarsa Therapeutics, Inc.
18.28. Teva Pharmaceutical Industries Ltd.
18.29. Zealand Pharma A/S

List of Figures

FIGURE 1. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL ORAL PROTEINS & PEPTIDES MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY FORMULATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA ORAL PROTEINS & PEPTIDES MARKET SIZE, 2018-2032 (USD MILLION)

List of Tables

TABLE 1. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY INSULIN-BASED PROTEINS, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY INSULIN-BASED PROTEINS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY INSULIN-BASED PROTEINS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY INSULIN-BASED PROTEINS, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY COMBINATION INSULIN PRODUCTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY COMBINATION INSULIN PRODUCTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY COMBINATION INSULIN PRODUCTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY LONG-ACTING INSULIN ANALOGUES, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY LONG-ACTING INSULIN ANALOGUES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY LONG-ACTING INSULIN ANALOGUES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY RAPID-ACTING INSULIN ANALOGUES, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY RAPID-ACTING INSULIN ANALOGUES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY RAPID-ACTING INSULIN ANALOGUES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY RECOMBINANT HUMAN INSULIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY RECOMBINANT HUMAN INSULIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY RECOMBINANT HUMAN INSULIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PEPTIDE THERAPEUTICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PEPTIDE THERAPEUTICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PEPTIDE THERAPEUTICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PEPTIDE THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY CALCITONIN-BASED THERAPIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY CALCITONIN-BASED THERAPIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY CALCITONIN-BASED THERAPIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY VASOPRESSIN ANALOGS, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY VASOPRESSIN ANALOGS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY VASOPRESSIN ANALOGS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY CAPSULE FORMULATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY CAPSULE FORMULATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY CAPSULE FORMULATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY LIQUID FORMULATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY LIQUID FORMULATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY LIQUID FORMULATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY POWDER FORMULATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY POWDER FORMULATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY POWDER FORMULATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY TABLET FORMULATIONS, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY TABLET FORMULATIONS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY TABLET FORMULATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PHASE I & II CLINICAL TRIALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PHASE I & II CLINICAL TRIALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PHASE I & II CLINICAL TRIALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PHASE III CLINICAL TRIALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PHASE III CLINICAL TRIALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PHASE III CLINICAL TRIALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY POST-MARKET SURVEILLANCE, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY POST-MARKET SURVEILLANCE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY POST-MARKET SURVEILLANCE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PRECLINICAL STUDIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PRECLINICAL STUDIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PRECLINICAL STUDIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY CANCER TREATMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY CANCER TREATMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY CANCER TREATMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DIABETES MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DIABETES MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DIABETES MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY HORMONAL DISORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY HORMONAL DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY HORMONAL DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY RESEARCH LABORATORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY RESEARCH LABORATORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 85. AMERICAS ORAL PROTEINS & PEPTIDES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 86. AMERICAS ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 87. AMERICAS ORAL PROTEINS & PEPTIDES MARKET SIZE, BY INSULIN-BASED PROTEINS, 2018-2032 (USD MILLION)
TABLE 88. AMERICAS ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PEPTIDE THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 89. AMERICAS ORAL PROTEINS & PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 90. AMERICAS ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2032 (USD MILLION)
TABLE 91. AMERICAS ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 92. AMERICAS ORAL PROTEINS & PEPTIDES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 93. NORTH AMERICA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 94. NORTH AMERICA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 95. NORTH AMERICA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY INSULIN-BASED PROTEINS, 2018-2032 (USD MILLION)
TABLE 96. NORTH AMERICA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PEPTIDE THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 97. NORTH AMERICA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 98. NORTH AMERICA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2032 (USD MILLION)
TABLE 99. NORTH AMERICA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 100. NORTH AMERICA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 101. LATIN AMERICA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 102. LATIN AMERICA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 103. LATIN AMERICA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY INSULIN-BASED PROTEINS, 2018-2032 (USD MILLION)
TABLE 104. LATIN AMERICA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PEPTIDE THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 105. LATIN AMERICA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 106. LATIN AMERICA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2032 (USD MILLION)
TABLE 107. LATIN AMERICA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 108. LATIN AMERICA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 110. EUROPE, MIDDLE EAST & AFRICA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 111. EUROPE, MIDDLE EAST & AFRICA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY INSULIN-BASED PROTEINS, 2018-2032 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PEPTIDE THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2032 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 117. EUROPE ORAL PROTEINS & PEPTIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 118. EUROPE ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 119. EUROPE ORAL PROTEINS & PEPTIDES MARKET SIZE, BY INSULIN-BASED PROTEINS, 2018-2032 (USD MILLION)
TABLE 120. EUROPE ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PEPTIDE THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 121. EUROPE ORAL PROTEINS & PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 122. EUROPE ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2032 (USD MILLION)
TABLE 123. EUROPE ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 124. EUROPE ORAL PROTEINS & PEPTIDES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 125. MIDDLE EAST ORAL PROTEINS & PEPTIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 126. MIDDLE EAST ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 127. MIDDLE EAST ORAL PROTEINS & PEPTIDES MARKET SIZE, BY INSULIN-BASED PROTEINS, 2018-2032 (USD MILLION)
TABLE 128. MIDDLE EAST ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PEPTIDE THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 129. MIDDLE EAST ORAL PROTEINS & PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 130. MIDDLE EAST ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2032 (USD MILLION)
TABLE 131. MIDDLE EAST ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 132. MIDDLE EAST ORAL PROTEINS & PEPTIDES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 133. AFRICA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 134. AFRICA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 135. AFRICA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY INSULIN-BASED PROTEINS, 2018-2032 (USD MILLION)
TABLE 136. AFRICA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PEPTIDE THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 137. AFRICA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 138. AFRICA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2032 (USD MILLION)
TABLE 139. AFRICA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 140. AFRICA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 141. ASIA-PACIFIC ORAL PROTEINS & PEPTIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 142. ASIA-PACIFIC ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 143. ASIA-PACIFIC ORAL PROTEINS & PEPTIDES MARKET SIZE, BY INSULIN-BASED PROTEINS, 2018-2032 (USD MILLION)
TABLE 144. ASIA-PACIFIC ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PEPTIDE THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 145. ASIA-PACIFIC ORAL PROTEINS & PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 146. ASIA-PACIFIC ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2032 (USD MILLION)
TABLE 147. ASIA-PACIFIC ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 148. ASIA-PACIFIC ORAL PROTEINS & PEPTIDES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 149. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 150. ASEAN ORAL PROTEINS & PEPTIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 151. ASEAN ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 152. ASEAN ORAL PROTEINS & PEPTIDES MARKET SIZE, BY INSULIN-BASED PROTEINS, 2018-2032 (USD MILLION)
TABLE 153. ASEAN ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PEPTIDE THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 154. ASEAN ORAL PROTEINS & PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 155. ASEAN ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2032 (USD MILLION)
TABLE 156. ASEAN ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 157. ASEAN ORAL PROTEINS & PEPTIDES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 158. GCC ORAL PROTEINS & PEPTIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 159. GCC ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 160. GCC ORAL PROTEINS & PEPTIDES MARKET SIZE, BY INSULIN-BASED PROTEINS, 2018-2032 (USD MILLION)
TABLE 161. GCC ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PEPTIDE THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 162. GCC ORAL PROTEINS & PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 163. GCC ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2032 (USD MILLION)
TABLE 164. GCC ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 165. GCC ORAL PROTEINS & PEPTIDES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 166. EUROPEAN UNION ORAL PROTEINS & PEPTIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 167. EUROPEAN UNION ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 168. EUROPEAN UNION ORAL PROTEINS & PEPTIDES MARKET SIZE, BY INSULIN-BASED PROTEINS, 2018-2032 (USD MILLION)
TABLE 169. EUROPEAN UNION ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PEPTIDE THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 170. EUROPEAN UNION ORAL PROTEINS & PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 171. EUROPEAN UNION ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2032 (USD MILLION)
TABLE 172. EUROPEAN UNION ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 173. EUROPEAN UNION ORAL PROTEINS & PEPTIDES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 174. BRICS ORAL PROTEINS & PEPTIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 175. BRICS ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 176. BRICS ORAL PROTEINS & PEPTIDES MARKET SIZE, BY INSULIN-BASED PROTEINS, 2018-2032 (USD MILLION)
TABLE 177. BRICS ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PEPTIDE THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 178. BRICS ORAL PROTEINS & PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 179. BRICS ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2032 (USD MILLION)
TABLE 180. BRICS ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 181. BRICS ORAL PROTEINS & PEPTIDES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 182. G7 ORAL PROTEINS & PEPTIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 183. G7 ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 184. G7 ORAL PROTEINS & PEPTIDES MARKET SIZE, BY INSULIN-BASED PROTEINS, 2018-2032 (USD MILLION)
TABLE 185. G7 ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PEPTIDE THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 186. G7 ORAL PROTEINS & PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 187. G7 ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2032 (USD MILLION)
TABLE 188. G7 ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 189. G7 ORAL PROTEINS & PEPTIDES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 190. NATO ORAL PROTEINS & PEPTIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 191. NATO ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 192. NATO ORAL PROTEINS & PEPTIDES MARKET SIZE, BY INSULIN-BASED PROTEINS, 2018-2032 (USD MILLION)
TABLE 193. NATO ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PEPTIDE THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 194. NATO ORAL PROTEINS & PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 195. NATO ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2032 (USD MILLION)
TABLE 196. NATO ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 197. NATO ORAL PROTEINS & PEPTIDES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 198. GLOBAL ORAL PROTEINS & PEPTIDES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 199. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 200. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 201. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY INSULIN-BASED PROTEINS, 2018-2032 (USD MILLION)
TABLE 202. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PEPTIDE THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 203. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 204. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2032 (USD MILLION)
TABLE 205. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 206. UNITED STATES ORAL PROTEINS & PEPTIDES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
TABLE 207. CHINA ORAL PROTEINS & PEPTIDES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 208. CHINA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 209. CHINA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY INSULIN-BASED PROTEINS, 2018-2032 (USD MILLION)
TABLE 210. CHINA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY PEPTIDE THERAPEUTICS, 2018-2032 (USD MILLION)
TABLE 211. CHINA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 212. CHINA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY DEVELOPMENT STAGE, 2018-2032 (USD MILLION)
TABLE 213. CHINA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 214. CHINA ORAL PROTEINS & PEPTIDES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Oral Proteins & Peptides market report include:

AbbVie Inc.
Amgen Inc.
Amryt Pharma plc
Astellas Pharma Inc.
AstraZeneca PLC
Biocon Limited
Boehringer Ingelheim International GmbH
Catalent, Inc.
Entera Bio Ltd. by DNA Biomedical Solutions
F. Hoffmann-La Roche AG
Hunan Huateng Pharmaceutical Co., Ltd. by Tasly Capital
Johnson & Johnson Services, Inc.
Merck KGaA
Novartis AG
Novo Nordisk A/S
Oramed Pharmaceuticals Inc.
PeptiDream Inc.
Pfizer, Inc.
Protagonist Therapeutics, Inc.
Proxima Concepts Limited
Rani Therapeutics, LLC
Sanofi S.A.
Tarsa Therapeutics, Inc.
Teva Pharmaceutical Industries Ltd.
Zealand Pharma A/S

Table Information

Report Attribute	Details
No. of Pages	187
Published	January 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 2.86 Billion
Forecasted Market Value ( USD ) by 2032	$ 3.99 Billion
Compound Annual Growth Rate	5.5%
Regions Covered	Global
No. of Companies Mentioned	26

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3504EUR$3,939USD£3,037GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€3779EUR$4,249USD£3,276GBP
SITE LICENSE PDF, Excel and Online Access	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5123EUR$5,759USD£4,440GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€6199EUR$6,969USD£5,372GBP

Market Snapshot: Oral Proteins and Peptides Market Size and Growth

Scope & Segmentation

Key Takeaways

Tariff Impact: Navigating Trade Policy and Localization

Methodology & Data Sources

Why This Report Matters

Conclusion

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Oral Proteins and Peptides Market Report 2025

Oral Proteins and Peptides Market Report and Forecast 2025-2034

Oral Proteins and Peptides Market - Global Strategic Business Report

Oral Proteins & Peptides Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

Oral Proteins & Peptides Market by Molecule (Semaglutide, Linaclotide, Calcitonin), Drug Class (GLP-1 Receptor Agonist, GEP, CGRP), Therapeutic Area (Diabetes, Gastroenterology, Genetic Disorder), Formulation (Tablet, Capsule) - Global Forecast to 2030